本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Redhill Biopharma Ltd

1.91
-0.0162-0.84%
盤後1.91-0.0038-0.20%16:07 EDT
成交量:1.26萬
成交額:2.43萬
市值:335.30萬
市盈率:-0.29
高:1.94
開:1.93
低:1.91
收:1.93
資料載入中...
2025/04/10

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/16

SEC問詢函

Form CORRESP - Correspondence
2024/06/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/08

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

SEC問詢函

Form CORRESP - Correspondence
2024/02/09

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/26

SEC問詢函

Form CORRESP - Correspondence
2023/08/10

SEC問詢函

Form CORRESP - Correspondence
2023/06/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/04/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/01/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals